Genova Biotechniques Private Limited, a active private limited company, was established on 05 July 2001 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U01110TG2001PTC036979. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹6.00 Cr and a paid-up capital of ₹5.11 Cr.
It upholds a compliant status. Its leadership includes Trimurthulu Guna (Whole-Time Director), Nurjahan Shaik (Additional Director), Mitra Puchhalapalli (Managing Director). Past directors included Krishnaiah Bollineni, Gopichand Mannam, Venkata Reddy Alla. It holds ₹1.86 M open charges and no settled loans. Its latest AGM occurred on 28 September 2024, with the balance sheet filed on 31 March 2024. It is based at 8-2-502/1/A, Jivi Towers Road No. 7, Banjara Hills, Hyderabad, Telangana, 500034.
U01110TG2001PTC036979
036979
05 July 2001
₹6.00 Cr
₹5.11 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Genova Biotechniques Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Trimurthulu Guna | Whole-Time Director | 02 Nov 2009 | Current |
| Nurjahan Shaik | Additional Director | 06 Jan 2023 | Current |
| Mitra Puchhalapalli | Managing Director | 05 Jul 2001 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 11 Nov 2009 | Past |
| Pramod Abcsdd | Director | 11 Nov 2009 | Past |
| Pramod Abcsdd | Director | 17 Jul 2007 | Past |
| Pramod Abcsdd | Director | 24 Feb 2017 | Past |
| Pramod Abcsdd | Director | 06 Apr 2007 | Past |
| Pramod Abcsdd | Director | 20 Dec 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Genova Biotechniques Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.1% increase. The company also saw a substantial improvement in profitability, with a 49.99% increase in profit. The company's net worth Soared by an impressive increase of 27.37%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Genova Biotechniques had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹1,859,300.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Mar 2021 | Hdfc Bank Limited | ₹1.86 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Genova Biotechniques, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Genova Biotechniques, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genova Biotechniques's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Genova Biotechniques Private Limited last Annual general meeting of members was held on 28 Sep 2024 as per latest MCA records. was documented.
Genova Biotechniques Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
The activity Nurjahan Shaik was appointed as a Additional Director was appointed as a Additional Director on 06 Jan 2023 & has been associated with this company since 2 years 11 months . was completed.
The activity A charge with Hdfc Bank Limited amounted to Rs. 0.19 Cr with Charge ID 100443977 was registered on 25 Mar 2021. was completed.
The activity Trimurthulu Guna was appointed as a Whole-time director was appointed as a Whole-time director on 02 Nov 2009 & has been associated with this company since 16 years 1 month . was completed.
Progress on Mitra Puchhalapalli was appointed as a Managing Director was appointed as a Managing Director on 05 Jul 2001 & has been associated with this company since 24 years 5 months . was documented.
Genova Biotech Co. Ltd. (Changzhou, China) received a $50 million investment from an undisclosed subsidiary of Tasly Holdings Group Co. Ltd. (Shanghai....
The CIN of Genova Biotechniques Private Limited is U01110TG2001PTC036979.
Genova Biotechniques Private Limited is headquartered at 8-2-502/1/A, Jivi Towers Road No. 7, Banjara Hills, Hyderabad, Telangana, 500034.
Genova Biotechniques Private Limited was incorporated on 05 July 2001.
The current directors of Genova Biotechniques Private Limited are
The primary industry of Genova Biotechniques Private Limited is Manufacturing.
Genova Biotechniques Private Limited is unlisted.
The authorized capital of Genova Biotechniques Private Limited is ₹6.00 Cr, and the paid-up capital is ₹5.11 Cr.
The compliance status of Genova Biotechniques Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX